Latest Breaking News On - Theta license - Page 1 : comparemela.com

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted.

Yujiros hataRamon kempWerner helicaseBiosciences incGlobal head of oncology early developmentExchange commissionDrug administrationPol theta helicase inhibitorInvestigational new drugPol theta helicasePol thetaVice presidentGlobal headOncology early developmentChief executive officerTheta license